{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:30:45Z","timestamp":1791855045746,"version":"4.3.4"},"reference-count":102,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Major depressive disorder (MDD) and diabetes mellitus (DM) remain among the most prevalent diseases and the most significant challenges faced by medicine in the 21st century. The frequent co-occurrence and bidirectional relationship between the two conditions necessitates the identification of treatment strategies that benefit both. The purpose of this study was to systematically review and meta-analyze data on the efficacy and safety of agomelatine (AGO) in the treatment of patients with depression with comorbid diabetes to explore its potential mechanism of action in both diseases and its impact on diabetic parameters. Following PRISMA guidelines, a total of 11 studies were identified, both preclinical and clinical trials. Agomelatine has shown great potential as a treatment option for patients with diabetes and comorbid depression and anxiety. In addition to improving depressive and anxiety symptoms, it is also beneficial in glycemic control. A meta-analysis demonstrated a statistically significant reduction in glycated hemoglobin (HbA1C) and fasting blood glucose (FBG) levels following AGO administration over a period of 8\u201316 weeks. The administration of agomelatine was found to result in a significantly greater reduction in HbA1C than that observed with the selective serotonin reuptake inhibitor (SSRI) medications (namely fluoxetine, sertraline, and paroxetine) during 12\u201316 weeks of therapy. Furthermore, AGO has been found to be at least as effective as SSRIs in reducing depressive symptoms and more effective than SSRIs in reducing anxiety symptoms. The safety of such treatment is similar to SSRIs; no severe adverse events were reported, and the incidence of some side effects, such as insomnia and sexual dysfunction, are even less often reported. Particularly promising is also its potential action in improving some diabetic complications reported in preclinical trials. This might be through mechanisms involving the reduction in oxidative stress, anti-inflammatory effects, and potentially noradrenergic or NMDA receptor modulation. Further clinical studies on larger sample sizes, as well as elucidating its mechanisms of action, especially in the context of diabetic complications, are needed. Research should also focus on identifying the patient subpopulations most likely to benefit from agomelatine treatment.<\/jats:p>","DOI":"10.3390\/ijms252312631","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T03:59:01Z","timestamp":1732507141000},"page":"12631","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and Safety of Agomelatine in Depressed Patients with Diabetes: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9312-2976","authenticated-orcid":false,"given":"Adam","family":"G\u0119dek","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland"},{"name":"Third Department of Psychiatry, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szymon","family":"Modrzejewski","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Medical University of Lublin, 20-059 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2224-3711","authenticated-orcid":false,"given":"Micha\u0142","family":"Materna","sequence":"additional","affiliation":[{"name":"Babinski Clinical Hospital, 30-393 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zofia","family":"Szular","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5352-601X","authenticated-orcid":false,"given":"Adam","family":"Wichniak","sequence":"additional","affiliation":[{"name":"Third Department of Psychiatry, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0642-6075","authenticated-orcid":false,"given":"Pawe\u0142","family":"Mierzejewski","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1423-2289","authenticated-orcid":false,"given":"Monika","family":"Dominiak","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, Regional, and National Burden of Diabetes from 1990 to 2021, with Projections of Prevalence to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Guerrero Fern\u00e1ndez de Alba, I., Gimeno-Miguel, A., Poblador-Plou, B., Gimeno-Feliu, L.A., Ioakeim-Skoufa, I., Rojo-Mart\u00ednez, G., Forjaz, M.J., and Prados-Torres, A. (2020). Association between Mental Health Comorbidity and Health Outcomes in Type 2 Diabetes Mellitus Patients. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-76546-9"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Lopez-de-Andres, A., Jimenez-Garcia, R., de Miguel-D\u00edez, J., Hern\u00e1ndez-Barrera, V., Del Barrio, J.L., Carabantes-Alarcon, D., Zamorano-Leon, J.J., and Noriega, C. (2022). Sex-Related Disparities in the Prevalence of Depression among Patients Hospitalized with Type 2 Diabetes Mellitus in Spain, 2011\u20132020. J. Clin. Med., 11.","DOI":"10.3390\/jcm11216260"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Choo, C.C., Chew, P.K.H., Ho, C.S., and Ho, R.C. (2018). Quality of Life in Patients With a Major Mental Disorder in Singapore. Front. Psychiatry, 9.","DOI":"10.3389\/fpsyt.2018.00727"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Albai, O., Braha, A., Timar, B., and Timar, R. (2024). Predictive Factors for Altered Quality of Life in Patients with Type 2 Diabetes Mellitus. J. Clin. Med., 13.","DOI":"10.3390\/jcm13154389"},{"key":"ref_6","unstructured":"COVID-19 Mental Disorders Collaborators (2021). Global Prevalence and Burden of Depressive and Anxiety Disorders in 204 Countries and Territories in 2020 Due to the COVID-19 Pandemic. Lancet, 398, 1700\u20131712."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kurdi, S.M., Alamer, A., Albaggal, A., Alsuwaiket, M., Alotaibi, F.M., Asiri, I.M., Alshayban, D.M., Alsultan, M.M., Alshehail, B., and Almalki, B.A. (2024). The Association between Self-Care Activities and Depression in Adult Patients with Type 2 Diabetes in Saudi Arabia: A Cross-Sectional Web-Based Survey Study. J. Clin. Med., 13.","DOI":"10.3390\/jcm13020419"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Atasoy, S., Johar, H., Fleischer, T., Beutel, M., Binder, H., Braehler, E., Schomerus, G., Z\u00f6ller, D., Kruse, J., and Ladwig, K.-H. (2022). Depression Mediates the Association Between Childhood Emotional Abuse and the Onset of Type 2 Diabetes: Findings From German Multi-Cohort Prospective Studies. Front. Psychiatry, 13.","DOI":"10.3389\/fpsyt.2022.825678"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Abualhamael, S.A., Baig, M., Alghamdi, W., Gazzaz, Z.J., Al-Hayani, M., and Bazi, A. (2023). Quality of Life, Stress, Anxiety and Depression and Associated Factors among People with Type 2 Diabetes Mellitus in Western Region Saudi Arabia. Front. Psychiatry, 14.","DOI":"10.3389\/fpsyt.2023.1282249"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.neubiorev.2016.07.011","article-title":"Alterations in Emotion Generation and Regulation Neurocircuitry in Depression and Eating Disorders: A Comparative Review of Structural and Functional Neuroimaging Studies","volume":"68","author":"Donofry","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jad.2009.09.021","article-title":"Pathways Linking Socioeconomic Status to Obesity through Depression and Lifestyle Factors among Young US Adults","volume":"123","author":"Beydoun","year":"2010","journal-title":"J. Affect. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Dziurkowska, E., and Wesolowski, M. (2021). Cortisol as a Biomarker of Mental Disorder Severity. J. Clin. Med., 10.","DOI":"10.3390\/jcm10215204"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1017\/S0033291721000088","article-title":"The Influence of Comorbid Depression and Overweight Status on Peripheral Inflammation and Cortisol Levels","volume":"52","author":"McLaughlin","year":"2022","journal-title":"Psychol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e45776","DOI":"10.2196\/45776","article-title":"Association Between Joint Physical Activity and Dietary Quality and Lower Risk of Depression Symptoms in US Adults: Cross-Sectional NHANES Study","volume":"9","author":"Liang","year":"2023","journal-title":"JMIR Public Health Surveill."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2337\/dc17-1566","article-title":"The Bidirectional Association Between Depression and Severe Hypoglycemic and Hyperglycemic Events in Type 1 Diabetes","volume":"41","author":"Gilsanz","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e14671","DOI":"10.1111\/dme.14671","article-title":"The Bidirectional Longitudinal Association between Depressive Symptoms and HbA(1c): A Systematic Review and Meta-Analysis","volume":"39","author":"Beran","year":"2022","journal-title":"Diabet. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Liu, X., Haagsma, J., Sijbrands, E., Buijks, H., Boogaard, L., Mackenbach, J.P., Erasmus, V., and Polinder, S. (2020). Anxiety and Depression in Diabetes Care: Longitudinal Associations with Health-Related Quality of Life. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-57647-x"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1007\/s00125-022-05723-4","article-title":"Depression, Diabetes, Comorbid Depression and Diabetes and Risk of All-Cause and Cause-Specific Mortality: A Prospective Cohort Study","volume":"65","author":"Prigge","year":"2022","journal-title":"Diabetologia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2147\/DMSO.S249163","article-title":"Acute Complications of Diabetes and Its Predictors among Adult Diabetic Patients at Jimma Medical Center, Southwest Ethiopia","volume":"13","author":"Fekadu","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ravender, R., Roumelioti, M.-E., Schmidt, D.W., Unruh, M.L., and Argyropoulos, C. (2024). Chronic Kidney Disease in the Older Adult Patient with Diabetes. J. Clin. Med., 13.","DOI":"10.3390\/jcm13020348"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/jdi.13480","article-title":"Update in the Epidemiology, Risk Factors, Screening, and Treatment of Diabetic Retinopathy","volume":"12","author":"Lin","year":"2021","journal-title":"J. Diabetes Investig."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.neuron.2023.05.003","article-title":"New Perspectives in Diabetic Neuropathy","volume":"111","author":"Eid","year":"2023","journal-title":"Neuron"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.tem.2020.01.007","article-title":"Chronic Diabetes Complications: The Need to Move beyond Classical Concepts","volume":"31","author":"Mauricio","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/oby.22969","article-title":"Antidepressant Medications and Weight Change: A Narrative Review","volume":"28","author":"Gill","year":"2020","journal-title":"Obesity"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1111\/obr.12934","article-title":"Effects of Antidepressant and Antipsychotic Use on Weight Gain: A Systematic Review","volume":"20","author":"Marti","year":"2019","journal-title":"Obes. Rev. Off. J. Int. Assoc. Study Obes."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1017\/neu.2016.54","article-title":"Use of Antidepressants in Patients with Depression and Comorbid Diabetes Mellitus: A Systematic Review","volume":"29","author":"Roopan","year":"2017","journal-title":"Acta Neuropsychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1016\/j.clnu.2021.06.007","article-title":"Effects of Melatonin Supplementation on Diabetes: A Systematic Review and Meta-Analysis of Randomized Clinical Trials","volume":"40","author":"Delpino","year":"2021","journal-title":"Clin. Nutr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13098-020-00537-z","article-title":"Melatonin: New Insights on Its Therapeutic Properties in Diabetic Complications","volume":"12","author":"Pourhanifeh","year":"2020","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/fcp.12224","article-title":"Effect of Subacute Agomelatine Treatment on Painful Diabetic Neuropathy: Involvement of Catecholaminergic Mechanisms","volume":"30","author":"Aydin","year":"2016","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/ijcp.12112","article-title":"Agomelatine and Sertraline for the Treatment of Depression in Type 2 Diabetes Mellitus","volume":"67","author":"Karaiskos","year":"2013","journal-title":"Int. J. Clin. Pract."},{"key":"ref_31","unstructured":"Higgins, J., and Green, S. (2024, January 31). Cochrane Handbook for Systematic Reviews of Interventions: Online Version 5.1.0. Cochrane Colab. Available online: www.training.cochrane.org\/handbook."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A Revised Tool for Assessing Risk of Bias in Randomised Trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-Bias VISualization (Robvis): An R Package and Shiny Web App for Visualizing Risk-of-Bias Assessments","volume":"12","author":"McGuinness","year":"2020","journal-title":"Res. Synth. Methods"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/j.pain.0000000000000738","article-title":"Agomelatine: A New Opportunity to Reduce Neuropathic Pain-Preclinical Evidence","volume":"158","author":"Chenaf","year":"2017","journal-title":"Pain"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Can, \u00d6.D., \u00dc\u00e7el, U.\u0130., Demir \u00d6zkay, \u00dc., and Ulup\u0131nar, E. (2018). The Effect of Agomelatine Treatment on Diabetes-Induced Cognitive Impairments in Rats: Concomitant Alterations in the Hippocampal Neuron Numbers. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19082461"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/fcp.12413","article-title":"Agomelatine Pretreatment Prevents Development of Hyperglycemia and Hypoinsulinemia in Streptozotocin-Induced Diabetes in Mice","volume":"33","author":"Ozcan","year":"2019","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1080\/01616412.2020.1757895","article-title":"Agomelatine Potentiates Anti-Nociceptive Effects of Morphine in a Mice Model for Diabetic Neuropathy: Involvement of NMDA Receptor Subtype NR1 within the Raphe Nucleus and Periaqueductal Grey","volume":"42","author":"Ozcan","year":"2020","journal-title":"Neurol. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.biopha.2016.12.102","article-title":"The Antioxidant Role of Agomelatine and Gallic Acid on Oxidative Stress in STZ Induced Type I Diabetic Rat Testes","volume":"87","author":"Yigitturk","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"109646","DOI":"10.1016\/j.intimp.2022.109646","article-title":"Agomelatine Improves Streptozotocin-Induced Diabetic Nephropathy through Melatonin Receptors\/SIRT1 Signaling Pathway","volume":"115","author":"Mahmoud","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_40","first-page":"4304","article-title":"Comparative Effect of Agomelatine Versus Escitalopram on Glycemic Control and Symptoms of Depression in Patients with Type 2 Diabetes Mellitus and Depression","volume":"6","author":"Kumar","year":"2015","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.2147\/NDT.S167608","article-title":"Agomelatine versus Fluoxetine in Glycemic Control and Treating Depressive and Anxiety Symptoms in Type 2 Diabetes Mellitus Subjects: A Single-Blind Randomized Controlled Trial","volume":"14","author":"Che","year":"2018","journal-title":"Neuropsychiatry Dis. Treat."},{"key":"ref_42","first-page":"1307","article-title":"Comparison of Paroxetine and Agomelatine in Depressed Type 2 Diabetes Mellitus Patients: A Double-Blind, Randomized, Clinical Trial","volume":"11","author":"Kang","year":"2015","journal-title":"Neuropsychiatry Dis. Treat."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"22934","DOI":"10.18632\/aging.203586","article-title":"Agomelatine Might Be More Appropriate for Elderly, Depressed, Type 2 Diabetes Mellitus Patients than Paroxetine\/Fluoxetine","volume":"13","author":"Liang","year":"2021","journal-title":"Aging"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Srisurapanont, M., Suttajit, S., Kosachunhanun, N., Likhitsathian, S., Suradom, C., and Maneeton, B. (2022). Antidepressants for Depressed Patients with Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis of Short-Term Randomized Controlled Trials. Neurosci. Biobehav. Rev., 139.","DOI":"10.1016\/j.neubiorev.2022.104731"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"102866","DOI":"10.1016\/j.ajp.2021.102866","article-title":"Antidepressant Efficacy of Agomelatine: Meta-Analysis of Placebo Controlled and Active Comparator Studies","volume":"65","author":"Maddukuri","year":"2021","journal-title":"Asian J. Psychiatry"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/YIC.0000000000000509","article-title":"Efficacy and Safety of Agomelatine versus SSRIs\/SNRIs for Post-Stroke Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"39","author":"Chen","year":"2024","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4088\/JCP.09m05347blu","article-title":"Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients with Major Depressive Disorder: A Randomized, Double-Blind Comparison with Sertraline","volume":"71","author":"Kasper","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"g1888","DOI":"10.1136\/bmj.g1888","article-title":"Antidepressant Efficacy of Agomelatine: Meta-Analysis of Published and Unpublished Studies","volume":"348","author":"Taylor","year":"2014","journal-title":"BMJ"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1017\/S1461145711001301","article-title":"Efficacy of Agomelatine in Major Depressive Disorder: Meta-Analysis and Appraisal","volume":"15","author":"Singh","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40120-023-00470-z","article-title":"Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine","volume":"12","author":"Stein","year":"2023","journal-title":"Neurol. Ther."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Owino, S., Buonfiglio, D.D.C., Tchio, C., and Tosini, G. (2019). Melatonin Signaling a Key Regulator of Glucose Homeostasis and Energy Metabolism. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00488"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.clnesp.2024.07.015","article-title":"Effects of Melatonin Supplementation on Markers of Inflammation and Oxidative Stress in Patients with Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"63","author":"Fard","year":"2024","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"113879","DOI":"10.1016\/j.ecoenv.2022.113879","article-title":"Melatonin Improves Mitochondrial Function by Preventing Mitochondrial Fission in Cadmium-Induced Rat Proximal Tubular Cell Injury via SIRT1-PGC-1\u03b1 Pathway Activation","volume":"242","author":"Dong","year":"2022","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"116173","DOI":"10.1016\/j.taap.2022.116173","article-title":"Melatonin Attenuates LPS-Induced Ovarian Toxicity via Modulation of SIRT-1, PI3K\/PAkt, PErk1\/2 and NF\u0138B\/COX-2 Expressions","volume":"451","author":"Pal","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Wang, P., Zhang, S., Lin, S., and Lv, Z. (2022). Melatonin Ameliorates Diabetic Hyperglycaemia-Induced Impairment of Leydig Cell Steroidogenic Function through Activation of SIRT1 Pathway. Reprod. Biol. Endocrinol., 20.","DOI":"10.1186\/s12958-022-00991-6"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4093\/dmj.2013.37.5.315","article-title":"SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential","volume":"37","author":"Kitada","year":"2013","journal-title":"Diabetes Metab. J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2337\/ds18-0033","article-title":"Diabetes Management in the Elderly","volume":"31","author":"Leung","year":"2018","journal-title":"Diabetes Spectr. A Publ. Am. Diabetes Assoc."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"119600","DOI":"10.1016\/j.lfs.2021.119600","article-title":"Agomelatine Prevents Gentamicin Nephrotoxicity by Attenuating Oxidative Stress and TLR-4 Signaling, and Upregulating PPAR\u03b3 and SIRT1","volume":"278","author":"Mahmoud","year":"2021","journal-title":"Life Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/pcn.12371","article-title":"Effect of Subchronic Administration of Agomelatine on Brain Energy Metabolism and Oxidative Stress Parameters in Rats","volume":"70","author":"Souza","year":"2016","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/papr.12145","article-title":"The Role of Descending Inhibitory Pathways on Chronic Pain Modulation and Clinical Implications","volume":"14","author":"Kwon","year":"2014","journal-title":"Pain Pract."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1172\/JCI43766","article-title":"Central Modulation of Pain","volume":"120","author":"Ossipov","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejphar.2014.04.028","article-title":"Serotonergic Modulation in Neuropathy Induced by Oxaliplatin: Effect on the 5HT2C Receptor","volume":"735","author":"Mannelli","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejpain.2008.06.007","article-title":"The Nociceptive Mechanism of 5-Hydroxytryptamine Released into the Peripheral Tissue in Acute Inflammatory Pain in Rats","volume":"13","author":"Nakajima","year":"2009","journal-title":"Eur. J. Pain"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2007.03.029","article-title":"Possible Involvement of Spinal Noradrenergic Mechanisms in the Antiallodynic Effect of Intrathecally Administered 5-HT2C Receptor Agonists in the Rats with Peripheral Nerve Injury","volume":"567","author":"Obata","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pain.2003.12.019","article-title":"Antiallodynic Effects of Intrathecally Administered 5-HT2C Receptor Agonists in Rats with Nerve Injury","volume":"108","author":"Obata","year":"2004","journal-title":"Pain"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrd3140","article-title":"Agomelatine, the First Melatonergic Antidepressant: Discovery, Characterization and Development","volume":"9","author":"Renard","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1111\/bph.12720","article-title":"Agomelatine: Mechanism of Action and Pharmacological Profile in Relation to Antidepressant Properties","volume":"171","author":"Delagrange","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejphar.2015.02.048","article-title":"Antihyperalgesic and Antiallodynic Effects of Mianserin on Diabetic Neuropathic Pain: A Study on Mechanism of Action","volume":"756","author":"Can","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1124\/jpet.110.176586","article-title":"Increased Presynaptic and Postsynaptic A2-Adrenoceptor Activity in the Spinal Dorsal Horn in Painful Diabetic Neuropathy","volume":"337","author":"Chen","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejphar.2008.06.087","article-title":"Role of A2-Adrenoceptors in Enhancement of Antinociceptive Effect in Diabetic Mice","volume":"592","author":"Omiya","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2013.12.016","article-title":"The Antiallodynic Action of Nortriptyline and Terbutaline Is Mediated by \u03922 Adrenoceptors and \u03b4 Opioid Receptors in the Ob\/Ob Model of Diabetic Polyneuropathy","volume":"1546","author":"Salvat","year":"2014","journal-title":"Brain Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/157015909790031201","article-title":"Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise","volume":"7","author":"Marks","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"108223","DOI":"10.1016\/j.clineuro.2024.108223","article-title":"Serotonin Norepinephrine Reuptake Inhibitors in Managing Neuropathic Pain Following Spinal and Non-Spinal Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"239","author":"Sutedja","year":"2024","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3748\/wjg.v20.i5.1298","article-title":"Antinociceptive Effects of Novel Melatonin Receptor Agonists in Mouse Models of Abdominal Pain","volume":"20","author":"Chen","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejphar.2015.07.010","article-title":"Antinociceptive Properties of Selective MT(2) Melatonin Receptor Partial Agonists","volume":"764","author":"Comai","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.j.pain.0000460311.71572.5f","article-title":"Selective Melatonin MT2 Receptor Ligands Relieve Neuropathic Pain through Modulation of Brainstem Descending Antinociceptive Pathways","volume":"156","author":"Palazzo","year":"2015","journal-title":"Pain"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1567202612666150102151900","article-title":"Melatonin Leads to Axonal Regeneration, Reduction in Oxidative Stress, and Improved Functional Recovery Following Sciatic Nerve Injury","volume":"12","author":"Kaya","year":"2015","journal-title":"Curr. Neurovasc. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.neuropharm.2009.11.018","article-title":"Functional and Biochemical Evidence Indicating Beneficial Effect of Melatonin and Nicotinamide Alone and in Combination in Experimental Diabetic Neuropathy","volume":"58","author":"Negi","year":"2010","journal-title":"Neuropharmacology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-079X.2010.00821.x","article-title":"Melatonin Modulates Neuroinflammation and Oxidative Stress in Experimental Diabetic Neuropathy: Effects on NF-\u039aB and Nrf2 Cascades","volume":"50","author":"Negi","year":"2011","journal-title":"J. Pineal Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4137\/CMO.S4132","article-title":"Melatonin, a Promising Role in Taxane-Related Neuropathy","volume":"4","author":"Nahleh","year":"2010","journal-title":"Clin. Med. Insights Oncol."},{"key":"ref_81","first-page":"91","article-title":"Effects of melatonin on nociception processes in experimentally model of neurophatic pain","volume":"49","author":"Zurowski","year":"2008","journal-title":"Folia Med. Cracov."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejphar.2007.09.006","article-title":"Melatonin Reduces Formalin-Induced Nociception and Tactile Allodynia in Diabetic Rats","volume":"577","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.pain.2007.01.025","article-title":"Oral and Spinal Melatonin Reduces Tactile Allodynia in Rats via Activation of MT2 and Opioid Receptors","volume":"132","year":"2007","journal-title":"Pain"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejphar.2004.02.055","article-title":"Hippocampal Synaptic Plasticity and Glutamate Receptor Regulation: Influences of Diabetes Mellitus","volume":"490","author":"Trudeau","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0166-2236(00)01656-8","article-title":"Cognition and Synaptic Plasticity in Diabetes Mellitus","volume":"23","author":"Gispen","year":"2000","journal-title":"Trends Neurosci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s001250051335","article-title":"Learning and Hippocampal Synaptic Plasticity in Streptozotocin-Diabetic Rats: Interaction of Diabetes and Ageing","volume":"43","author":"Kamal","year":"2000","journal-title":"Diabetologia"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Martin, V., Alla\u00efli, N., Euvrard, M., Marday, T., Riffaud, A., Franc, B., Moca\u00ebr, E., Gabriel, C., Fossati, P., and Lehericy, S. (2017). Effect of Agomelatine on Memory Deficits and Hippocampal Gene Expression Induced by Chronic Social Defeat Stress in Mice. Sci. Rep., 8.","DOI":"10.1038\/srep45907"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e485","DOI":"10.1038\/tp.2014.125","article-title":"Hippocampal and Behavioral Dysfunctions in a Mouse Model of Environmental Stress: Normalization by Agomelatine","volume":"4","author":"Boulle","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.acthis.2016.02.007","article-title":"Effect of Agomelatine on Adult Hippocampus Apoptosis and Neurogenesis Using the Stress Model of Rats","volume":"118","author":"Yucel","year":"2016","journal-title":"Acta Histochem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3109\/15622975.2013.765593","article-title":"Agomelatine, a Novel Intriguing Antidepressant Option Enhancing Neuroplasticity: A Critical Review","volume":"14","author":"Pompili","year":"2013","journal-title":"World J. Biol. Psychiatry Off. J. World Fed. Soc. Biol. Psychiatry"},{"key":"ref_91","first-page":"75","article-title":"Diabetic Encephalopathy: The Role of Oxidative Stress and Inflammation in Type 2 Diabetes","volume":"4","author":"Soares","year":"2012","journal-title":"Int. J. Interf. Cytokine Mediat. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/pchj.87","article-title":"Comparison of Stress-Induced and LPS-Induced Depressive-like Behaviors and the Alterations of Central Proinflammatory Cytokines MRNA in Rats","volume":"4","author":"Guan","year":"2015","journal-title":"PsyCh J."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1210\/en.2002-0142","article-title":"Functional Role of Inducible Nitric Oxide Synthase in the Induction of Male Germ Cell Apoptosis, Regulation of Sperm Number, and Determination of Testes Size: Evidence from Null Mutant Mice","volume":"144","author":"Lue","year":"2003","journal-title":"Endocrinology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.mce.2015.12.012","article-title":"Repetitive Exposure to Low-Dose X-Irradiation Attenuates Testicular Apoptosis in Type 2 Diabetic Rats, Likely via Akt-Mediated Nrf2 Activation","volume":"422","author":"Zhao","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000363239","article-title":"The Protective Effect of Granulocyte Colony-Stimulating Factor on Endometrium and Ovary in a Rat Model of Diabetes Mellitus","volume":"78","author":"Pala","year":"2014","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3109\/09513590.2014.929657","article-title":"High-Dose Atorvastatin Ameliorates the Uterine Microenvironment in Streptozotocin-Induced Diabetic Rats","volume":"30","author":"Zeybek","year":"2014","journal-title":"Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol."},{"key":"ref_97","first-page":"272","article-title":"Nitric Oxide and Chronic Gut Inflammation: Controversies in Inflammatory Bowel Disease","volume":"50","author":"Grisham","year":"2002","journal-title":"J. Investig. Med. Off. Publ. Am. Fed. Clin. Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nn1110","article-title":"NF-Kappa B Functions in Synaptic Signaling and Behavior","volume":"6","author":"Meffert","year":"2003","journal-title":"Nat. Neurosci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic Kidney Disease: Challenges, Progress, and Possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"436","DOI":"10.18632\/aging.100468","article-title":"The Tellurium Compound, AS101, Increases SIRT1 Level and Activity and Prevents Type 2 Diabetes","volume":"4","author":"Gertler","year":"2012","journal-title":"Aging"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Foresto-Neto, O., Albino, A.H., Arias, S.C.A., Faustino, V.D., Zambom, F.F.F., Cenedeze, M.A., Elias, R.M., Malheiros, D.M.A.C., Camara, N.O.S., and Fujihara, C.K. (2020). NF-\u039aB System Is Chronically Activated and Promotes Glomerular Injury in Experimental Type 1 Diabetic Kidney Disease. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.00084"},{"key":"ref_102","unstructured":"Srisurapanont, M. (2024, May 05). Antidepressants for Depressed Patients with Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis of Short-Term Randomized Controlled Trials. Figshare. Dataset. Available online: https:\/\/figshare.com\/articles\/dataset\/Antidepressants_for_Depressed_Patients_with_Type_2_Diabetes_Mellitus_A_Systematic_Review_and_Network_Meta-Analysis_of_Short-Term_Randomized_Controlled_Trials\/20055056."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/23\/12631\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:38:46Z","timestamp":1760114326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/23\/12631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,25]]},"references-count":102,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["ijms252312631"],"URL":"https:\/\/doi.org\/10.3390\/ijms252312631","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,25]]}}}